Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of disease stage and treatment outcomes on the dynamics of liver functions during and after treatment of hepatitis C with directly acting antivirals.
El Kassas M, Alboraie M, El-Sayed M, Elbehiry S, Sherief A, Youssef M, Moaz I, El Tahan A, Abdeen N, Eysa B, Aziz AA, Tawheed A, Ezzat S, Hassany M. El Kassas M, et al. Among authors: el sayed m, el tahan a. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e302-e307. doi: 10.1097/MEG.0000000000002043. Eur J Gastroenterol Hepatol. 2021. PMID: 34080825
An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.
El Kassas M, Alboraie M, Omran D, Salaheldin M, Wifi MN, ElBadry M, El Tahan A, Ezzat S, Moaz E, Farid AM, Omar H, Abouelkhair M, Afify S, Elsaeed K, Shazly Y, Doss W, Esmat G. El Kassas M, et al. Among authors: el tahan a. Expert Rev Gastroenterol Hepatol. 2018 Dec;12(12):1265-1272. doi: 10.1080/17474124.2018.1476137. Epub 2018 May 24. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29757684
Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study.
El Kassas M, Alboraie M, El Badry M, Youssef N, Omar H, El Sheemy RY, Al Balakosy A, Ashraf Ahmed Mohamed O, Gamal Naguib Meleak G, Dabbous H, Hassan Ahmed Fouad M, Wifi MN, Zaky S, Tahoon M, El Tahan A, El-Raey F, Ezzat S, Doss W. El Kassas M, et al. Among authors: el sheemy ry, el raey f, el badry m, el tahan a. Int J Infect Dis. 2020 Jul;96:367-370. doi: 10.1016/j.ijid.2020.04.022. Epub 2020 Apr 20. Int J Infect Dis. 2020. PMID: 32325275 Free article.
Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience.
El Kassas M, Omran D, Elsaeed K, Alboraie M, Elakel W, El Tahan A, Abd El Latif Y, Nabeel MM, Korany M, Ezzat S, El-Serafy M, ElShazly Y, Doss W, Esmat G. El Kassas M, et al. Among authors: el serafy m, el tahan a. J Interferon Cytokine Res. 2018 Feb;38(2):81-85. doi: 10.1089/jir.2017.0121. Epub 2018 Jan 22. J Interferon Cytokine Res. 2018. PMID: 29356573
Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes.
El Kassas M, Alboraie M, Elsaeed K, Ahmed Y, El Tahan A, Alhaddad O, Salaheldin M, Kabbash I, El Badry M, Fathy T, El-Serafy M, ElShazly Y, Doss W, Esmat G. El Kassas M, et al. Among authors: el serafy m, el badry m, el tahan a. Am J Ther. 2018 Nov/Dec;25(6):e776-e779. doi: 10.1097/MJT.0000000000000784. Am J Ther. 2018. PMID: 30124480 No abstract available.
High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results.
El Kassas M, Alboraie M, Omar H, El Latif YA, Algaber MA, El Tahan A, El Halwagy H, Afify S, Elserafy M, Elsaeed K, Doss W. El Kassas M, et al. Among authors: el halwagy h, el latif ya, el tahan a. J Med Virol. 2022 Feb;94(2):667-674. doi: 10.1002/jmv.25478. Epub 2019 Apr 15. J Med Virol. 2022. PMID: 30950069
Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt.
El Kassas M, Funk AL, Abd El Latif Y, Vasiliu A, Sherief A, Shimakawa Y, Youssef N, El Tahan A, Elbadry M, Farid AM, El Shazly Y, Doss W, Esmat G, Fontanet A. El Kassas M, et al. Among authors: el tahan a, el shazly y. Aliment Pharmacol Ther. 2018 Jun;47(11):1564-1566. doi: 10.1111/apt.14628. Aliment Pharmacol Ther. 2018. PMID: 29878419 No abstract available.
84 results